Spero Therapeutics Inc (NASDAQ:SPRO) has a beta value of 1.10 and has seen 24.26 million shares traded in the last trading session. The company, currently valued at $139.78M, closed the last trade at $2.50 per share which meant it gained $0.37 on the day or 17.37% during that session. The SPRO stock price is 0.8% off its 52-week high price of $2.48 and 79.6% above the 52-week low of $0.51.
The consensus among analysts is that Spero Therapeutics Inc (SPRO) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Spero Therapeutics Inc (NASDAQ:SPRO) trade information
Sporting 17.37% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the SPRO stock price touched $2.50 or saw a rise of 10.71%. Year-to-date, Spero Therapeutics Inc shares have moved 142.72%, while the 5-day performance has seen it change 258.17%. Over the past 30 days, the shares of Spero Therapeutics Inc (NASDAQ:SPRO) have changed 279.94%.
Spero Therapeutics Inc (SPRO) estimates and forecasts
The company’s shares have gained 117.39% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 17.67% over the past 5 years. Earnings growth for 2025 is a modest 9.45% while over the next 5 years, the company’s earnings are expected to increase by 7.97%.
SPRO Dividends
Spero Therapeutics Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Spero Therapeutics Inc (NASDAQ:SPRO)’s Major holders
The top two institutional holders are ANSON FUNDS MANAGEMENT LP with over 3.75 million shares worth more than $4.88 million. As of 2024-06-30, ANSON FUNDS MANAGEMENT LP held 7.007% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 1.77 million shares as of 2024-06-30. The firm’s total holdings are worth over $2.3 million and represent 3.3079% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 2.09% shares in the company for having 1.17 shares of worth $2.92 million while later fund manager owns 587.34 shares of worth $1.47 million as of Mar 31, 2025 , which makes it owner of about 1.05% of company’s outstanding stock.
